Sikiri, P., Mazul, B., Seiwerth, S., Grabarevi, Z., Rucman, R., Petek, M., Jagi, V., Turkovi, B., Rotkvi, I., Mise, S., Zorici, I., Jurina, L., Konjevoda, P., Hanzevacki, M., Gjurasin, M., Separovi, J., Ljubanovi, D., Artukovi, B., Bratuli, M., Tisljar, M., Sumajstorci, J
The Phase 2 obesity trial published in the New England Journal of Medicine reported substantial weight reduction over 48 weeks, while a separate Phase 2 trial in people with type 2 diabetes evaluated glycemic and body-weight effects
What you see online may look like a protocol, but those very specific instructions are internet consensusnot medical consensus
They set a lot of fires
| 2024 Edition Peptide quality is key for both safety and success in research